Protagonist Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 78.96 million compared to USD 127.39 million a year ago. Basic loss per share from continuing operations was USD 1.39 compared to USD 2.6 a year ago.